236 related articles for article (PubMed ID: 14997850)
1. Therapeutic antibodies and antibody fusion proteins.
Rohrbach P; Broders O; Toleikis L; Dübel S
Biotechnol Genet Eng Rev; 2003; 20():137-63. PubMed ID: 14997850
[No Abstract] [Full Text] [Related]
2. Engineering mouse monoclonal antibodies for cancer immunotherapy.
Orlandi R
Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
[No Abstract] [Full Text] [Related]
3. Antibody-cytokine fusion proteins for the therapy of cancer.
Helguera G; Penichet ML
Methods Mol Med; 2005; 109():347-74. PubMed ID: 15585931
[TBL] [Abstract][Full Text] [Related]
4. Generation of antibody molecules through antibody engineering.
Kipriyanov SM
Methods Mol Biol; 2003; 207():3-25. PubMed ID: 12412465
[No Abstract] [Full Text] [Related]
5. Development of antibodies and chimeric molecules for cancer immunotherapy.
Waldmann TA; Morris JC
Adv Immunol; 2006; 90():83-131. PubMed ID: 16730262
[TBL] [Abstract][Full Text] [Related]
6. [Antibody-Based Drugs and Other Recombinant Proteins for Diagnostics and Therapy of Viral Infections, Autoimmune Diseases and Cancer].
Kuprash DV; Garib FY; Nedospasov SA
Mol Biol (Mosk); 2017; 51(6):883-885. PubMed ID: 29271953
[No Abstract] [Full Text] [Related]
7. Engineering antibodies for therapy.
Adair JR
Immunol Rev; 1992 Dec; 130():5-40. PubMed ID: 1286872
[TBL] [Abstract][Full Text] [Related]
8. The future of monoclonal antibody engineering.
Renner C; Hartmann F; Pfreundschuh M
Ann Hematol; 2001; 80 Suppl 3():B127-9. PubMed ID: 11757694
[No Abstract] [Full Text] [Related]
9. Radioimmunotherapy with engineered antibodies.
Russeva MG; Adams GP
Expert Opin Biol Ther; 2004 Feb; 4(2):217-31. PubMed ID: 14998779
[TBL] [Abstract][Full Text] [Related]
10. Antibody Engineering--IBC's 17th annual international conference. Antibody engineering and immunotherapeutics for the 21st century.
Bradbury A
IDrugs; 2007 Mar; 10(3):169-72. PubMed ID: 17351868
[No Abstract] [Full Text] [Related]
11. Improving the efficacy of antibody-based cancer therapies.
Carter P
Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic antibody gene transfer.
Marasco WA
Nat Biotechnol; 2005 May; 23(5):551-2. PubMed ID: 15877069
[No Abstract] [Full Text] [Related]
13. IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA.
Arnett SO; Teillaud JL; Wurch T; Reichert JM; Dunlop C; Huber M
MAbs; 2011; 3(2):133-52. PubMed ID: 21304271
[TBL] [Abstract][Full Text] [Related]
14. [Engineering Antibodies as Drugs: Principles and Practice].
Lugovskoy AA
Mol Biol (Mosk); 2017; 51(6):886-898. PubMed ID: 29271954
[TBL] [Abstract][Full Text] [Related]
15. Novel diagnostic and therapeutic strategies with genetically engineered human antibodies.
Ouwehand WH; Watkins N
Vox Sang; 1998; 74 Suppl 2():223-32. PubMed ID: 9704449
[TBL] [Abstract][Full Text] [Related]
16. Antibody-cytokine fusion proteins for cancer immunotherapy: an update on recent developments.
Müller D
BioDrugs; 2014 Apr; 28(2):123-31. PubMed ID: 24018469
[TBL] [Abstract][Full Text] [Related]
17. Engineering of antibodies for breast cancer therapy: construction of chimeric and humanized versions of the murine monoclonal antibody BrE-3.
Couto JR; Blank EW; Peterson JA; Kiwan R; Padlan EA; Ceriani RL
Adv Exp Med Biol; 1994; 353():55-9. PubMed ID: 7985542
[No Abstract] [Full Text] [Related]
18. CAR T-cell Therapy: A New Era in Cancer Immunotherapy.
Miliotou AN; Papadopoulou LC
Curr Pharm Biotechnol; 2018; 19(1):5-18. PubMed ID: 29667553
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic antibodies: magic bullets hit the target.
Gura T
Nature; 2002 Jun; 417(6889):584-6. PubMed ID: 12050630
[No Abstract] [Full Text] [Related]
20. Antibody-IL-2 fusion proteins: a novel strategy for immune protection.
Penichet ML; Harvill ET; Morrison SL
Hum Antibodies; 1997; 8(3):106-18. PubMed ID: 9322080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
